Challenges in implementing CD4 testing in resource-limited settings

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue SUPPL. 1, 2008, Pages

  Peter, Trevor ^a   Badrichani, Anne ^a   Wu, Emily ^a   Freeman, Richard ^a   Ncube, Bekezela ^a   Ariki, Fabiana ^a   Daily, Jennifer ^a   Shimada, Yoko ^a   Murtagh, Maurine ^a  

^a Clinton Foundation HIV/AIDS Initiative   (United States)

Author keywords

AIDS; Antiretroviral; Capacity building; CD4 count; HIV; Laboratory

Indexed keywords

ANTIRETROVIRUS AGENT;

ANALYTICAL EQUIPMENT; BIOASSAY; BIOTECHNOLOGY; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; DISEASE ACTIVITY; DRUG EFFICACY; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; PATIENT MONITORING; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; HEALTH CARE PLANNING; HOSPITAL INFORMATION SYSTEM; LABORATORY; MEDICAL TECHNOLOGY; METHODOLOGY; STANDARD;

CD4 LYMPHOCYTE COUNT; HEALTH RESOURCES; HUMANS; LABORATORIES; POINT-OF-CARE SYSTEMS; QUALITY CONTROL; TECHNOLOGY, MEDICAL;

EID: 42449142663     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20416     Document Type: Review

References (28)

1. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: Towards universal access. Recommendations for a public health approach. Geneva: World Health Organization; 2006.
2. World Health Organization. Antiretroviral therapy for HIV infection in infants and children in resource-limited settings: Towards universal access. Recommendations for a public health approach. Geneva: World Health Organization; 2006.
3. Song R, Jelagat J, Dzombo D, Mwalimu M, Mandaliya K, Shikely K, Essajee S. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya. Pediatrics 2007;120:856-861.
4. Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, Katabira E, Colebunders R, Quinn TC, Ronald A, Thomas DL, Kekitiinwa A; Academic Alliance for AIDS Care and Prevention in Africa. 2007. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 46:187-193.
5. Vajpayee M, Kaushik S, Mojumdar K, Sreenivas V. Antiretroviral treatment in resource-poor settings: A view from India. Indian J Med Sci 2007;61:390-397.
6. Bishai D, Colchero A, Durack DT. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings. AIDS 2007; 21:1333-1340.
7. Kagaayi J, Makumbi F, Nakigozi G, Wawer MJ, Gray RH, Serwadda D, Reynolds SJ. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. AIDS 2007;21:1208-1210.
8. Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther 2007;4:11.
9. Myung P, Pugatch D, Brady MF, Many P, Harwell JI, Lurie M, Tucker J. Directly observed highly active antiretroviral therapy for HIV-infected children in Cambodia. Am J Public Health 2007;97:974-977.
10. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM, Mwango A, Levy J, Abrams EJ, Bulterys M, Stringer JS. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007;298:1888-1899.
11. Moore DM, Awor A, Downing RS, Were W, Solberg P, Tu D, Chan K, Hogg RS, Mermin J. Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index. AIDS Res Ther 2007;4:1.
12. Gupta A, Gupte N, Bhosale R, Kakrani A, Kulkarni V, Nayak U, Thakar M, Sastry J, Bollinger RC; Byramji Jeejeebhoy Medical College-Johns Hopkins University Study Group. 2007. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy. J Acquir Immune Defic Syndr 46:338-342.
13. Marshall S, Sippy N, Broome H, Abayomi A. Quality control of the total lymphocyte count parameter obtained from routine haematology analyzers, and its relevance in HIV management. Afr J Med Med Sci 2006;35:161-163.
14. Landay A, Ho JL, Hom D, Russell T, Zwerner R, Minuty JG, Kataaha P, Mmiro F, Jackson B. A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS 1993;7:1565-1568.
15. Bi X, Gatanaga H, Tanaka M, Honda M, Ida S, Kimura S, Oka S. Modified Dynabeads method for enumerating CD4+ T-lymphocyte count for widespread use in resource-limited situations. J Acquir Immune Defic Syndr 2005;38:1-4.
16. Karcher H, Böhning D, Downing R, Mashate S, Harms G. Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda. Cytometry Part B Clin Cytom 2006;70B:163-169.
17. Mandy FF, Nicholson JK, McDougal JS;CDC. 2003Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention. MMWR Recommendation Report, Jan 31 2003. 52(RR-2). pp.1-13.
18. Jani V, Janossy G, Iqbal A, Mhalu FS, Lyamuya EF, Biberfeld G, Glencross DK, Scott L, Reilly JT, Granger V, Barnett D. Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings. J Immunol Methods 2001;257(1-2):145-154.
19. Warrino DE, DeGennaro LJ, Hanson M, Swindells S, Pirruccello SJ, Ryan WL. Stabilization of white blood cells and immunologic markers for extended analysis using flow cytometry. J Immunol Methods 2005;305(2):107-119.
20. Cheng X, Irimia D, Dixon M, Ziperstein JC, Demirci U, Zamir L, Tompkins RG, Toner M, Rodriguez WR. A microchip approach for practical label-free CD4+ T-cell counting of HIV-infected subjects in resource-poor settings. J Acquir Immune Defic Syndr 45:257-261.
21. Li X, Ymeti A, Lunter B, Breukers C, Tibbe AG, Terstappen LW, Greve J. CD4+ T lymphocytes enumeration by an easy-to-use single platform image cytometer for HIV monitoring in resource-constrained settings. Cytometry Part B Clin Cytom 2007;72B:397-407.
22. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted Pan Leucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 2002;50:69-77.
23. Pattanapanyasat K, Shain H, Noulsri E, Lerdwana S, Thepthai C, Prasertsilpa V, Likanonsakul S, Yothipitak P, Nookhai S, Eksaengsri A. A multicenter evaluation of the Pan Leucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand. Cytometry Part B Clin Cytom 2005;65A:29-36.
24. Buranapraditkun S, Nookhai S, Ubolyam S, Sirivichayakul S, Phanuphak P, Ruxrungtham K. Cost savings by reagent reduction in flow cytometry-based CD4+ T cell counts: An approach to improve accessibility for HIV management. Asian Pac J Allergy Immunol 2007;25:83-89.
25. Canadian Guidelines for Flow Cytometric Immunophenotyping, 2001. Centre for Infectious Disease Prevention and Control, Health Canada. Available online at http://www.phac-aspc.gc.ca/nlhi-lniv/ pdf/cd4_2001direc_e.pdf
26. Mashauri FM, Siza JE, Temu MM, Mngara JT, Kishamawe C, Changalucha JM. Assessment of quality assurance in HIV testing in health facilities in Lake Victoria zone, Tanzania. Tanzan Health Res Bull 2007; 9:110-114.
27. Mandy F, Bergeron M, Houle G, Bradley J, Fahey J. Impact of the International Program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Cytometry 2002;50:111-116.
28. Gratama JW, Kraan J, Keeney M, Granger V, Barnett D. Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. Cytometry 2002;50:92-101.